Stocks PDD Financial statements
Financial statementsPDD Holdings Inc. financial statements
Income statement, balance sheet and cash flow statement for the last 8 fiscal years, taken from the XBRL data PDD Holdings Inc. files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
| FY2018 | FY2019 | FY2020 | FY2020 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | 1,908 | 4,330 | 9,118 | 14,743 | 18,929 | 34,879 | 53,955 | 61,753 |
| Cost of revenue | 423 | 911 | 2,955 | 4,977 | 4,562 | 12,919 | 21,084 | 26,998 |
| Gross profit | 1,486 | 3,419 | 6,163 | 9,766 | 14,367 | 21,960 | 32,871 | 34,755 |
| Research and development | 162 | 556 | 1,056 | 1,411 | 1,506 | 1,543 | 1,734 | 2,359 |
| Selling and marketing | 1,955 | 3,903 | 6,313 | 7,030 | 7,879 | 11,576 | 15,248 | 17,916 |
| General and administrative | 939 | 186 | 231 | 242 | 575 | 574 | 1,035 | 1,167 |
| Operating expenses | 3,056 | 4,646 | 7,601 | 8,683 | 9,960 | 13,693 | 18,017 | 21,441 |
| Operating income | -1,571 | -1,226 | -1,438 | 1,082 | 4,408 | 8,268 | 14,854 | 13,313 |
| Interest expense | 21 | 116 | 193 | 7.49 | 6.2 | |||
| Interest income | 85.1 | 221 | 376 | 480 | 580 | 1,442 | 2,816 | 3,658 |
| Other non-operating income | -1.8 | 11.9 | 29.7 | 103 | 322 | 416 | 427 | 390 |
| Pre-tax income | -1,486 | -1,001 | -1,100 | 1,522 | 5,258 | 10,124 | 18,180 | 17,099 |
| Income tax | 0 | 303 | 685 | 1,669 | 2,777 | 3,108 | ||
| Net income | -1,486 | -1,001 | -1,100 | 1,219 | 4,573 | 8,455 | 15,403 | 13,991 |
| EBITDA | -1,498 | -1,135 | -1,338 | 1,317 | 4,730 | 8,378 | 14,951 | 13,399 |
| EPS, basic | -0.50 | -0.22 | -0.23 | 0.24 | 0.90 | 1.56 | 2.78 | 2.50 |
| EPS, diluted | -0.50 | -0.22 | -0.23 | 0.21 | 0.79 | 1.45 | 2.60 | 2.36 |
| Shares, basic (weighted) | 2,968 | 4,627 | 4,768 | 5,013 | 5.06 | 5,416 | 5,536 | 5,591 |
| Shares, diluted (weighted) | 2,968 | 4,627 | 4,768 | 5,714 | 5.76 | 5,840 | 5,917 | 5,930 |
Balance sheet
| FY2018 | FY2019 | FY2020 | FY2020 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 2,060 | 829 | 3,436 | 1,008 | 4,977 | 8,422 | 7,914 | 15,573 |
| Short-term investments | 1,110 | 5,069 | 9,893 | 13,576 | 16,690 | 22,171 | 37,509 | 44,817 |
| Inventory | 263 | 2.23 | ||||||
| Other current assets | 0.99 | 4.02 | 29.1 | 137 | 116 | 215 | 219 | 213 |
| Total current assets | 5,875 | 10,486 | 22,916 | 25,250 | 31,407 | 41,515 | 56,944 | 74,213 |
| Property, plant and equipment | 4.23 | 5.93 | 31.1 | 346 | 151 | 138 | 120 | 187 |
| Lease right-of-use assets | 74.3 | 96.5 | 147 | 205 | 578 | 694 | 695 | |
| Intangible assets | 375 | 286 | 196 | 110 | 19.4 | 2.98 | 2.63 | 2.2 |
| Other non-current assets | 26.6 | 72.3 | 1,115 | 2,578 | 2,445 | 6,754 | 11,427 | 14,973 |
| Total assets | 6,281 | 10,925 | 24,354 | 28,436 | 34,379 | 49,026 | 69,189 | 90,095 |
| Accounts payable | 324 | 701 | 174 | 306 | 577 | 2,381 | 3,874 | 4,671 |
| Accrued liabilities | 199 | 392 | ||||||
| Total current liabilities | 3,543 | 6,574 | 12,855 | 14,708 | 16,947 | 21,536 | 25,814 | 30,564 |
| Lease liabilities | 61.6 | 63.6 | 85.4 | 126 | 372 | 437 | 412 | |
| Other non-current liabilities | 1.06 | 0.45 | 0.16 | |||||
| Total liabilities | 3,543 | 7,385 | 15,131 | 16,649 | 17,304 | 22,653 | 26,266 | 30,982 |
| Paid-in capital | 4,235 | 5,960 | 13,287 | 14,961 | 14,390 | 15,112 | 16,143 | 17,985 |
| Retained earnings | -1,648 | -2,628 | -3,904 | -2,779 | 2,203 | 10,580 | 25,677 | 40,635 |
| Other comprehensive income | 151 | 208 | -161 | -395 | 482 | 665 | 1,072 | 303 |
| Shareholders' equity | 2,738 | 3,540 | 9,222 | 11,787 | 17,075 | 26,372 | 42,924 | 59,113 |
| Total equity | 2,738 | 3,540 | 9,222 | 11,787 | 17,075 | 26,372 | 42,924 | 59,113 |
| Total liabilities and equity | 6,281 | 10,925 | 24,354 | 28,436 | 34,379 | 49,026 | 69,189 | 90,095 |
| Shares outstanding | 4,456 | 5,278 | 5,503 | 5,569 | 5,694 |
Cash flow statement
| FY2018 | FY2019 | FY2020 | FY2020 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|---|---|---|
| Net income | -1,486 | -1,001 | -1,100 | 1,219 | 4,573 | 8,455 | 15,403 | 13,991 |
| Depreciation and amortization | 72.3 | 91.6 | 99.9 | 235 | 322 | 111 | 97.1 | 86 |
| Stock-based compensation | 995 | 367 | 554 | 749 | 1,119 | 997 | 1,354 | 1,135 |
| Deferred income tax | 0 | 0 | 0 | -0.03 | -149 | 113 | 30.4 | -26 |
| Change in receivables | -23.2 | -115 | 49.3 | 8.76 | 12.5 | -469 | 6.69 | -218 |
| Cash from operations | 1,130 | 2,129 | 4,321 | 4,517 | 7,033 | 13,263 | 16,704 | 15,292 |
| Capital expenditures | -3.98 | -3.94 | -6.6 | |||||
| Purchases of investments | -1,093 | -7,534 | -13,247 | -18,303 | -519 | -2,439 | -1,881 | -4,082 |
| Sales and maturities of investments | 592 | 156 | 981 | |||||
| Cash from investing | -1,098 | -4,068 | -5,879 | -5,581 | -3,242 | -7,807 | -16,215 | -6,209 |
| Cash from financing | 2,523 | 2,277 | 7,939 | -294 | 1.46 | -1,262 | 0.16 | -748 |
| Exchange rate effect | 79.5 | 64.7 | -21.4 | -22.8 | ||||
| Net change in cash | 2,634 | 403 | 6,360 | -1,381 | 3,807 | 4,152 | 605 | 8,085 |
| Free cash flow | 1,126 | 2,125 | 4,315 | |||||
| Income taxes paid | 708 | 812 | 2,397 | 3,089 |
Key metrics
Profitability
| Metric | Value | How it is calculated |
|---|---|---|
| Gross margin | 56.3% | Gross profit / revenue. |
| Operating margin | 21.6% | Operating income / revenue. |
| EBITDA margin | 21.7% | EBITDA (operating income + depreciation and amortization) / revenue. |
| Pre-tax margin | 27.7% | Pre-tax income / revenue. |
| Net margin | 22.7% | Net income / revenue. |
| Operating cash flow margin | 24.8% | Cash from operations / revenue. |
| Effective tax rate | 18.2% | Income tax / pre-tax income, when pre-tax income is positive. |
| Return on equity (ROE) | 27.4% | Net income / average shareholders' equity (opening and closing). Not shown when equity is negative. |
| Return on assets (ROA) | 17.6% | Net income / average total assets. |
| Return on invested capital (ROIC) | 27.7% | Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%. |
| R&D / revenue | 3.8% | Research and development expense / revenue. |
| Stock-based pay / revenue | 1.8% | Stock-based compensation (from the cash flow statement) / revenue. |
| D&A / revenue | 0.1% | Depreciation and amortization / revenue. |
Growth
| Metric | Value | How it is calculated |
|---|---|---|
| Revenue growth, 1y | 14.5% | Revenue vs the same period a year earlier. Only from a positive base. |
| Revenue CAGR, 3y | 48.3% | Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Revenue CAGR, 5y | 46.6% | Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Gross profit growth, 1y | 5.7% | Gross profit vs the same period a year earlier. Only from a positive base. |
| Gross profit CAGR, 3y | 34.2% | Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Gross profit CAGR, 5y | 41.3% | Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Operating income growth, 1y | -10.4% | Operating income vs the same period a year earlier. Only from a positive base. |
| Operating income CAGR, 3y | 44.6% | Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| EBITDA growth, 1y | -10.4% | EBITDA vs the same period a year earlier. Only from a positive base. |
| EBITDA CAGR, 3y | 41.5% | Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Net income growth, 1y | -9.2% | Net income vs the same period a year earlier. Only from a positive base. |
| Net income CAGR, 3y | 45.2% | Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| EPS growth, 1y | -9.2% | EPS vs the same period a year earlier. Only from a positive base. |
| EPS CAGR, 3y | 44.0% | Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Operating cash flow growth, 1y | -8.5% | Operating cash flow vs the same period a year earlier. Only from a positive base. |
| Operating cash flow CAGR, 3y | 29.6% | Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Operating cash flow CAGR, 5y | 28.8% | Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Book value growth, 1y | 37.7% | Book value vs the same period a year earlier. Only from a positive base. |
| Book value CAGR, 3y | 51.3% | Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Book value CAGR, 5y | 45.0% | Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Total assets growth, 1y | 30.2% | Total assets vs the same period a year earlier. Only from a positive base. |
| Total assets CAGR, 3y | 37.9% | Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Total assets CAGR, 5y | 29.9% | Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Share count change, 1y | 0.2% | Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution. |
| Share count change per year, 3y | 909.6% | Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution. |
| Share count change per year, 5y | 4.5% | Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution. |
Balance sheet health
| Metric | Value | How it is calculated |
|---|---|---|
| Current ratio | 2.43x | Current assets / current liabilities. |
| Quick ratio | 1.98x | (Cash + short-term investments + receivables) / current liabilities. |
| Cash ratio | 1.98x | (Cash + short-term investments) / current liabilities. |
| Liabilities / assets | 34.4% | Total liabilities / total assets. |
| Working capital | $43.65B | Current assets - current liabilities. |
| Goodwill and intangibles / assets | 0.0% | (Goodwill + intangible assets) / total assets. |
| Tangible book value | $59.11B | Shareholders' equity - goodwill - intangible assets. |
Efficiency
| Metric | Value | How it is calculated |
|---|---|---|
| Asset turnover | 0.78x | Revenue / average total assets. |
| Fixed asset turnover | 402x | Revenue / average property, plant and equipment. |
| Days payables | 58 days | 365 x average accounts payable / cost of revenue. |
Per share
| Metric | Value | How it is calculated |
|---|---|---|
| EPS, diluted | $2.36 | Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS. |
| EPS, basic | $2.50 | Net income per basic share, as reported (split-adjusted). |
| Revenue per share | $10.41 | Revenue / diluted weighted shares. |
| Operating cash flow per share | $2.58 | Cash from operations / diluted weighted shares. |
| Book value per share | $10.38 | Shareholders' equity / shares outstanding (diluted weighted shares when not reported). |
| Tangible book per share | $10.38 | Tangible book value / shares outstanding. |
| Cash per share | $10.61 | (Cash + short-term investments) / shares outstanding. |
Valuation
| Metric | Value | How it is calculated |
|---|---|---|
| Market cap | $110.41B | Share price x shares outstanding. |
| Enterprise value | $50.02B | Market cap + total debt - cash - short-term investments. |
| P/E | 7.89x | Market cap / net income. Only when net income is positive. |
| P/S | 1.79x | Market cap / revenue. |
| P/B | 1.87x | Market cap / shareholders' equity. Only when equity is positive. |
| Price / tangible book | 1.87x | Market cap / tangible book value, when positive. |
| P/OCF | 7.22x | Market cap / cash from operations, when positive. |
| EV/Sales | 0.81x | Enterprise value / revenue. |
| EV/EBIT | 3.76x | Enterprise value / operating income, when both are positive. |
| EV/EBITDA | 3.73x | Enterprise value / EBITDA, when both are positive. |
| Earnings yield | 12.7% | Net income / market cap (the inverse of P/E). |
| PEG | 0.18x | P/E / EPS growth per year over 3 years (in percent). Only when both are positive. |
What was PDD Holdings Inc.'s revenue in fiscal 2025?
PDD Holdings Inc. reported revenue of $61.75B for fiscal 2025, 14.5% higher than the year before.
Was PDD Holdings Inc. profitable in fiscal 2025?
Yes. Net income was $13.99B, a net margin of 22.7%.